ALBANY MOLECULAR RESEARCH (AMRI) provides contract chemistry expertise to leading pharmaceutical and biotechnology companies worldwide at all stages of the drug discovery process.

The firm was established as a chemistry-based drug discovery, development and manufacturing company with in-house analytical chemistry department. It built a  state-of-the-art analytical equipment.

Focus: The firm focuses on small molecule prescription drugs, identifying leads for validated targets, hit-to-lead optimization, scale-up, in vitro metabolism, and cGMP synthesis and manufacturing for clinical trials and commercial products. AMRI conducts it own proprietary research through its internal research programs in CNS/neurology, oncology, immune disorders and inflammatory diseases, i.e., irritable bowel diseases, psoriasis and asthma, for licensing of preclinical and clinical compounds to a commercialization partner. The firm’s library has a collection of natural product extracts for lead finding and its high-throughput screening provides access to them. www.albmolecular.com